Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Healthcare Biotechnology
Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Liminal BioSciences Inc.
Bullboard Posts
User Avatar Image
(0)
•••
Comment by joe9999on Nov 14, 2016 10:28am
207 Views
Post# 25456727

RE:American Society of Nephrology (Kidney Week) 2016 Nov 15-20

RE:American Society of Nephrology (Kidney Week) 2016 Nov 15-20

marcus1608 wrote:
Second try. Sorry, I don’t post very often.


Prometic will present at least 8 abstracts at this event.

PBI-4050 : Abstracts TH-PO192, TH-PO230, TH-PO330, TH-PO451, TH-PO452, TH-PO829

PBI-4547 : Abstract TH-PO453

PBI-4425 : Abstract TH-PO228


My reference : https://www.asn-online.org/education/kidneyweek/archives/

(Abstract Supplement)

Have a good reading !




CORRECTION about the abstracts presented by PROMETIC at this congress: On THURSDAY: THPO192, THPO451, THPO452, THPO453, On FRIDAY: FRPO330, FRPO829, On SATURDAY: SAPO228, SAPO230
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities